OBJECTIVE: An increasing number of states have passed recent policies prohibiting abortion in cases of fetal anomaly, most notably Down syndrome. Data to demonstrate the impact of these restrictions are lacking. Our study sought to evaluate the cost-effectiveness of these policies for pregnancies affected by Down syndrome. STUDY DESIGN: A decision-analytic model was constructed using TreeAge 2018 software. Probabilities, costs and utilities were derived from the literature. Our theoretical cohort was 212,646 women, based on the annual birth rate in states with these restrictive policies: North Dakota, Louisiana and Ohio. Our primary outcome was cost, and our secondary outcomes included: cost per quality-adjusted life year (QALY), procedure-related fetal loss (PRL), births affected by Down syndrome, intrauterine fetal demise (IUFD), and pregnancy termination. We considered direct medical, educational and economic lifetime costs for a person living with Down syndrome, in addition to the cost of prenatal screening and diagnostic tests, the cost of a 2 nd -trimester abortion, PRL or 3 rd -trimester IUFD and the cost of a hospital delivery. The cost-effectiveness threshold was set to $100,000 per QALY. The baseline probability of termination after a Down syndrome diagnosis was 67%. Sensitivity analyses were performed to determine the robustness of the model. RESULTS: In a theoretical cohort of 212,646 pregnant women, policies that exclude termination in cases of Down Syndrome result in an additional annual cost of $291 million, which corresponds to $1,369 per pregnant woman (Table 1) . It also results in a greater number of live births affected by Down syndrome-321 compared to 175 with no policy. Additionally, this policy leads to 12 more IUFDs and 157 fewer abortions, with an expected decrease of 727 QALYs. The number of PRLs is not expected to change with a policy ban. CONCLUSION: Policies restricting abortion in cases of a Down syndrome diagnosis result in fewer pregnancy terminations and lead to a greater economic burden. Policymakers should keep this in mind along with the ethical implications of these laws when deciding whether to enact them. OBJECTIVE: Fetal acidemia is associated with serious long-term sequelae, including cerebral palsy, hypoxic-ischemic encephalopathy, and death. While fetal acidemia is most often encountered after labor, it is also occasionally seen in the setting of prelabor cesarean. We aimed to estimate the incidence of fetal acidemia in women undergoing planned cesarean delivery and to identify maternal risk factors associated with fetal acidemia. STUDY DESIGN: This retrospective cohort study evaluated all women delivering live, non-anomalous neonates via scheduled cesarean at or beyond 37 weeks gestation from 2004 to 2014 at a single, academic tertiary care center with a universal cord gas policy. Women with multifetal gestations or onset of labor prior to cesarean were excluded from this study. Paired umbilical cord gases were collected immediately after delivery. The primary outcome was the incidence of fetal acidemia (umbilical artery pH 7.1). Univariate analysis was conducted to identify maternal and operative factors associated with acidemia. Multivariable logistic regression was used to adjust for confounders. RESULTS: Of 3,005 pregnancies meeting inclusion criteria, 121 (4.0%, 95% CI 3.3%-4.7%) were complicated by fetal acidemia. After controlling for confounders, hypertension, diabetes, incision to delivery time, prior cesarean, advanced maternal age, and macrosomia (birth weight 4000g) were not associated with acidemia. Caucasian race was protective (aRR 0.61, 95% CI 0.38-0.97) against acidemia, while maternal obesity (BMI 30 kg/m 2 ) was a significant risk factor for fetal acidemia (aRR 1.70, 95% CI 1.10-2.62). Notably, there was a dose-dependent relationship between increasing maternal BMI and incidence of fetal acidemia, with super morbidly obese women (BMI 50 kg/m 2 ) having a five-fold increased risk of fetal acidemia (13.2% v 2.6%, aRR 4.97, 95% CI 2.71-9.14; Table) . CONCLUSION: Maternal obesity is the only modifiable risk factor for fetal acidemia identified in this cohort of women undergoing ajog.org
OBJECTIVE: An increasing number of states have passed recent policies prohibiting abortion in cases of fetal anomaly, most notably Down syndrome. Data to demonstrate the impact of these restrictions are lacking. Our study sought to evaluate the cost-effectiveness of these policies for pregnancies affected by Down syndrome. STUDY DESIGN: A decision-analytic model was constructed using TreeAge 2018 software. Probabilities, costs and utilities were derived from the literature. Our theoretical cohort was 212,646 women, based on the annual birth rate in states with these restrictive policies: North Dakota, Louisiana and Ohio. Our primary outcome was cost, and our secondary outcomes included: cost per quality-adjusted life year (QALY), procedure-related fetal loss (PRL), births affected by Down syndrome, intrauterine fetal demise (IUFD), and pregnancy termination. We considered direct medical, educational and economic lifetime costs for a person living with Down syndrome, in addition to the cost of prenatal screening and diagnostic tests, the cost of a 2 nd -trimester abortion, PRL or 3 rd -trimester IUFD and the cost of a hospital delivery. The cost-effectiveness threshold was set to $100,000 per QALY. The baseline probability of termination after a Down syndrome diagnosis was 67%. Sensitivity analyses were performed to determine the robustness of the model. RESULTS: In a theoretical cohort of 212,646 pregnant women, policies that exclude termination in cases of Down Syndrome result in an additional annual cost of $291 million, which corresponds to $1,369 per pregnant woman (Table 1) . It also results in a greater number of live births affected by Down syndrome-321 compared to 175 with no policy. Additionally, this policy leads to 12 more IUFDs and 157 fewer abortions, with an expected decrease of 727 QALYs. The number of PRLs is not expected to change with a policy ban. CONCLUSION: Policies restricting abortion in cases of a Down syndrome diagnosis result in fewer pregnancy terminations and lead to a greater economic burden. Policymakers should keep this in mind along with the ethical implications of these laws when deciding whether to enact them. OBJECTIVE: Fetal acidemia is associated with serious long-term sequelae, including cerebral palsy, hypoxic-ischemic encephalopathy, and death. While fetal acidemia is most often encountered after labor, it is also occasionally seen in the setting of prelabor cesarean. We aimed to estimate the incidence of fetal acidemia in women undergoing planned cesarean delivery and to identify maternal risk factors associated with fetal acidemia. STUDY DESIGN: This retrospective cohort study evaluated all women delivering live, non-anomalous neonates via scheduled cesarean at or beyond 37 weeks gestation from 2004 to 2014 at a single, academic tertiary care center with a universal cord gas policy. Women with multifetal gestations or onset of labor prior to cesarean were excluded from this study. Paired umbilical cord gases were collected immediately after delivery. The primary outcome was the incidence of fetal acidemia (umbilical artery pH 7.1). Univariate analysis was conducted to identify maternal and operative factors associated with acidemia. Multivariable logistic regression was used to adjust for confounders. RESULTS: Of 3,005 pregnancies meeting inclusion criteria, 121 (4.0%, 95% CI 3.3%-4.7%) were complicated by fetal acidemia. After controlling for confounders, hypertension, diabetes, incision to delivery time, prior cesarean, advanced maternal age, and macrosomia (birth weight 4000g) were not associated with acidemia. Caucasian race was protective (aRR 0.61, 95% CI 0.38-0.97) against acidemia, while maternal obesity (BMI 30 kg/m 2 ) was a significant risk factor for fetal acidemia (aRR 1.70, 95% CI 1.10-2.62). Notably, there was a dose-dependent relationship between increasing maternal BMI and incidence of fetal acidemia, with super morbidly obese women (BMI 50 kg/m 2 ) having a five-fold increased risk of fetal acidemia (13.2% v 2.6%, aRR 4.97, 95% CI 2.71-9.14; Table) . CONCLUSION: Maternal obesity is the only modifiable risk factor for fetal acidemia identified in this cohort of women undergoing ajog.org Poster Session I Supplement to JANUARY 2019 American Journal of Obstetrics & Gynecology S155
